The present invention relates to novel pyrimidine derivatives such as compounds of the formula (I):
and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.
本发明涉及新型
嘧啶衍
生物,例如式(I)化合物,以及这些化合物或其制药组合物在治疗疾病,特别是由
大麻素2受体活性介导的疼痛方面的应用。